Search PDMR transactions

Notifier
Name of person with notification obligation
Blake Leitch
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Blake Leitch
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
XSpray Pharma AB (publ)
Issuer´s LEI code
549300NGRQCNZ3X4L157
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share XSpray Pharma AB SE0009973563 Acquisition 44,939 Quantity 14.797319 SEK 12/06/2026 UBS TRADING
Share XSpray Pharma AB SE0009973563 Allotment 5,061 Quantity 15.14079 SEK 15/06/2026 UBS TRADING
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
XSpray Pharma AB SE0009973563 Acquisition 12/06/2026 UBS TRADING 44,939 (Quantity) 14.797319 SEK
XSpray Pharma AB SE0009973563 Allotment 15/06/2026 UBS TRADING 5,061 (Quantity) 15.14079 SEK
<< Back